Access comprehensive financial analyses and make smarter investments - get
the
Manual of Investments
on Amazon
!
Get
the
Manual of Investments
on Amazon
!
Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
ZYME
Zymeworks gains NMPA approval for Zanidatamab
| 2025-06-02 |
PHARMACEUTICAL
Zymeworks' Zanidatamab approved for HER2+ biliary tract cancer in China
| 2025-06-01 |
PHARMACEUTICAL
Zymeworks Outlines Strategic Priorities and Projects Cash Runway into 2027
| 2025-01-09 |
PHARMACEUTICAL
